Leerink Partners reiterated an Outperform rating on Diplomat Pharmacy (NYSE: DPLO), and raised the price target to $38.00 (from $36.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

After-Hours Stock Movers 08/09: (CLNE) (OCN) (YELP) Higher; (GEVO) (SPWR) (MYGN) Lower (more...)August 9, 2016 6:01 PM Diplomat Pharmacy (DPLO) Tops Q2 EPS by 2cAugust 9, 2016 4:40 PM Diplomat Announces 2nd Quarter Financial ResultsAugust 9, 2016 4:15 PM Trading Radar for 8/9: Disney (DIS), Coach (COH), Valeant Pharma (VRX), Wayfair (W), Yelp (YELP) ReportAugust 8, 2016 2:26 PM